Conserved statin-mediated activation of the p38-MAPK pathway protects Caenorhabditis elegans from the cholesterol-independent effects of statins
Objective: Statins are a group of medications that reduce cholesterol synthesis by inhibiting the activity of HMG-CoA reductase, a key enzyme in the mevalonate pathway. The clinical use of statins to lower excess cholesterol levels has revolutionized the cardiovascular field and increased the surviv...
Saved in:
Main Authors: | Irina Langier Goncalves (Author), Sharon Tal (Author), Liza Barki-Harrington (Author), Amir Sapir (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of prescription size on statin adherence and cholesterol levels
by: Mehler Phillip S, et al.
Published: (2007) -
Modeling neurodegeneration in Caenorhabditis elegans
by: Kim A. Caldwell, et al.
Published: (2020) -
Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency
by: Chinwong D, et al.
Published: (2015) -
Mechanisms of iron metabolism in Caenorhabditis elegans
by: Elizabeth A Leibold, et al.
Published: (2014) -
Caenorhabditis elegans for research on cancer hallmarks
by: Julián Cerón
Published: (2023)